Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics in Central American healthy volunteers: interethnic variability.

Drug metabolism and personalized therapy - 1 Mar 2015

Céspedes-Garro Carolina, Naranjo María-Eugenia G, Ramírez Ronald, Serrano Víctor, Fariñas Humberto, Barrantes Ramiro, LLerena Adrián

Abstract excerpt

Ethnicity is one of the major factors involved in interindividual variability to drug response. This study aims to describe the frequency of the most relevant pharmacogenetic biomarkers and metabolic phenotypes in Central American healthy volunteers and to determine its interethnic variability. Twenty-six original research articles on allelic, genotypes or metabolic phenotype frequencies were analyzed, in which a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arylamine N-Acetyltransferase
Share to Central America

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 Enzyme System

Share to Genetic Markers

Share to Healthy Volunteers

Share to HLA Antigens

Share to Indians, Central American

Share to Receptors, LDL

Source

Identifiers

PMID: 25490028
DOI: 10.1515/dmdi-2014-0025

Genes

NAT2
LDLR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics in Central American healthy volunteers: interethnic variability.PMID 25490028Read ↗

Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.Semantic proximity Read ↗

Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes.Semantic proximity Read ↗

Genetic structure of pharmacogenetic biomarkers in Brazil inferred from a systematic review and population-based cohorts: a RIBEF/EPIGEN-Brazil initiative.Semantic proximity Read ↗

Pharmacogenetic landscape of Metabolic Syndrome components drug response in Tunisia and comparison with worldwide populations.Semantic proximity Read ↗

Population Diversity in Pharmacogenetics: A Latin American Perspective.Semantic proximity Read ↗

Exploring the distribution of genetic markers of pharmacogenomics relevance in Brazilian and Mexican populations.Semantic proximity Read ↗

Pharmacogenomics in Asian Subpopulations and Impacts on Commonly Prescribed MedicationsSemantic proximity Read ↗

Pharmacogenetic Variation and Its Clinical Relevance in a Latin American Rural Population.Semantic proximity Read ↗

Pharmacogenetic profile of a South Portuguese population: results from the pilot study of the European Health Examination Survey in Portugal.Semantic proximity Read ↗

Race, ethnicity, ancestry, and pharmacogenetics.Semantic proximity Read ↗

Ethnic background and CYP2D6 genetic polymorphisms in Costa Ricans.Semantic proximity Read ↗

Pharmacogenomics, ethnicity, and susceptibility genes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.